VeriMom¿Es kaempferol rhamnoside seguro durante el embarazo?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for kaempferol 3‑rhamnoside (Afzelin, CAS 482-39-3). ECHA substance information shows only company notifications for irritation endpoints (no H360/H361 harmonised classification). Peer‑reviewed literature for this compound reports pharmacology/toxicity studies (neuroprotective, metabolic) but no reproductive or teratology data, so there is no evidence of reproductive hazard. Low dermal/systemic absorption is expected for a polar flavonol glycoside in topical use, so exposure from normal cosmetic topical use is judged low but measurable. Sources: ECHA substance page, PubChem entry, PubMed studies.
Related ingredients
Frequently asked questions
- ¿Es kaempferol rhamnoside seguro durante el embarazo?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for kaempferol 3‑rhamnoside (Afzelin, CAS 482-39-3). ECHA substance information shows only company notifications for irritation endpoints (no H360/H361 harmonised classification). Peer‑reviewed literature for this compound reports pharmacology/toxicity studies (neuroprotective, metabolic) but no reproductive or teratology data, so there is no evidence of reproductive hazard. Low dermal/systemic absorption is expected for a polar flavonol glycoside in topical use, so exposure from normal cosmetic topical use is judged low but measurable. Sources: ECHA substance page, PubChem entry, PubMed studies.
- ¿Es kaempferol rhamnoside seguro durante la lactancia?
- No data indicate reproductive or lactation-specific toxicity or endocrine disruption for afzelin. With low expected dermal absorption for the glycoside, maternal systemic exposure from cosmetic topical use would likely be low; therefore transfer to breastmilk is unlikely but not studied.
- ¿Es kaempferol rhamnoside seguro para la piel del bebé?
- No infant-specific safety or developmental toxicity data were found. The compound is a flavonol glycoside (polar) and not known to be a developmental toxicant; hazard is therefore scored 0. Because infant skin has an immature barrier and higher surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2) to reflect higher potential per‑kg absorption if applied to baby skin.
- ¿Cómo puntúa VeriMom a kaempferol rhamnoside?
- VeriMom puntúa kaempferol rhamnoside en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a kaempferol rhamnoside en el embarazo?
- Consulta nuestra lista de alternativas seguras a kaempferol rhamnoside según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.